249 related articles for article (PubMed ID: 24374502)
1. Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants.
Appaiahgari MB; Glass R; Singh S; Taneja S; Rongsen-Chandola T; Bhandari N; Mishra S; Vrati S
Vaccine; 2014 Feb; 32(6):651-6. PubMed ID: 24374502
[TBL] [Abstract][Full Text] [Related]
2. Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants.
Rongsen-Chandola T; Strand TA; Goyal N; Flem E; Rathore SS; Arya A; Winje BA; Lazarus R; Shanmugasundaram E; Babji S; Sommerfelt H; Vainio K; Kang G; Bhandari N
Vaccine; 2014 Aug; 32 Suppl 1():A134-9. PubMed ID: 25091668
[TBL] [Abstract][Full Text] [Related]
3. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants.
Moon SS; Groome MJ; Velasquez DE; Parashar UD; Jones S; Koen A; van Niekerk N; Jiang B; Madhi SA
Clin Infect Dis; 2016 Jan; 62(2):157-65. PubMed ID: 26400993
[TBL] [Abstract][Full Text] [Related]
4. Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants.
Chilengi R; Simuyandi M; Beach L; Mwila K; Becker-Dreps S; Emperador DM; Velasquez DE; Bosomprah S; Jiang B
PLoS One; 2016; 11(3):e0150100. PubMed ID: 26974432
[TBL] [Abstract][Full Text] [Related]
5. Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries?
Chan J; Nirwati H; Triasih R; Bogdanovic-Sakran N; Soenarto Y; Hakimi M; Duke T; Buttery JP; Bines JE; Bishop RF; Kirkwood CD; Danchin MD
Vaccine; 2011 Feb; 29(6):1242-7. PubMed ID: 21147127
[TBL] [Abstract][Full Text] [Related]
6. A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial.
Bhandari N; Sharma P; Taneja S; Kumar T; Rongsen-Chandola T; Appaiahgari MB; Mishra A; Singh S; Vrati S;
J Infect Dis; 2009 Aug; 200(3):421-9. PubMed ID: 19545211
[TBL] [Abstract][Full Text] [Related]
7. Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand.
Chen MY; Kirkwood CD; Bines J; Cowley D; Pavlic D; Lee KJ; Orsini F; Watts E; Barnes G; Danchin M
Hum Vaccin Immunother; 2017 May; 13(5):1126-1135. PubMed ID: 28059609
[TBL] [Abstract][Full Text] [Related]
8. A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC® in comparison with a licensed rotavirus vaccine in healthy infants.
Ella R; Babji S; Ciarlet M; Blackwelder WC; Vadrevu KM
Vaccine; 2019 Jul; 37(31):4407-4413. PubMed ID: 31178377
[TBL] [Abstract][Full Text] [Related]
9. Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants.
Parker EPK; Bronowski C; Sindhu KNC; Babji S; Benny B; Carmona-Vicente N; Chasweka N; Chinyama E; Cunliffe NA; Dube Q; Giri S; Grassly NC; Gunasekaran A; Howarth D; Immanuel S; Jere KC; Kampmann B; Lowe J; Mandolo J; Praharaj I; Rani BS; Silas S; Srinivasan VK; Turner M; Venugopal S; Verghese VP; Darby AC; Kang G; Iturriza-Gómara M
Nat Commun; 2021 Dec; 12(1):7288. PubMed ID: 34911947
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial.
Bhandari N; Sharma P; Glass RI; Ray P; Greenberg H; Taneja S; Saksena M; Rao CD; Gentsch JR; Parashar U; Maldonado Y; Ward RL; Bhan MK
Vaccine; 2006 Jul; 24(31-32):5817-23. PubMed ID: 16735085
[TBL] [Abstract][Full Text] [Related]
11. Contribution of Maternal Immunity to Decreased Rotavirus Vaccine Performance in Low- and Middle-Income Countries.
Mwila K; Chilengi R; Simuyandi M; Permar SR; Becker-Dreps S
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27847365
[TBL] [Abstract][Full Text] [Related]
12. Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries.
Otero CE; Langel SN; Blasi M; Permar SR
PLoS Pathog; 2020 Nov; 16(11):e1009010. PubMed ID: 33211756
[TBL] [Abstract][Full Text] [Related]
13. Lack of maternal antibodies to P serotypes may predispose neonates to infections with unusual rotavirus strains.
Ramachandran M; Vij A; Kumar R; Das BK; Gentsch JR; Bhan MK; Glass RI
Clin Diagn Lab Immunol; 1998 Jul; 5(4):527-30. PubMed ID: 9665961
[TBL] [Abstract][Full Text] [Related]
14. A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in India.
Ella R; Bobba R; Muralidhar S; Babji S; Vadrevu KM; Bhan MK
Hum Vaccin Immunother; 2018 Jul; 14(7):1791-1799. PubMed ID: 29543547
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.
Phua KB; Quak SH; Lee BW; Emmanuel SC; Goh P; Han HH; De Vos B; Bock HL
J Infect Dis; 2005 Sep; 192 Suppl 1():S6-S16. PubMed ID: 16088807
[TBL] [Abstract][Full Text] [Related]
16. Rotavirus-Specific Immunoglobulin A Responses Are Impaired and Serve as a Suboptimal Correlate of Protection Among Infants in Bangladesh.
Lee B; Carmolli M; Dickson DM; Colgate ER; Diehl SA; Uddin MI; Islam S; Hossain M; Rafique TA; Bhuiyan TR; Alam M; Nayak U; Mychaleckyj JC; McNeal MM; Petri WA; Qadri F; Haque R; Kirkpatrick BD
Clin Infect Dis; 2018 Jul; 67(2):186-192. PubMed ID: 29394355
[TBL] [Abstract][Full Text] [Related]
17. Natural immunity to rotavirus infection in children.
Malik J; Bhan MK; Ray P
Indian J Biochem Biophys; 2008 Aug; 45(4):219-28. PubMed ID: 18788471
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of a three dose and five dose oral human rotavirus vaccine (RIX4414) schedule in south Indian infants.
Kompithra RZ; Paul A; Manoharan D; Babji S; Sarkar R; Mathew LG; Kang G
Vaccine; 2014 Aug; 32 Suppl 1():A129-33. PubMed ID: 25091666
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam.
Shin S; Anh DD; Zaman K; Yunus M; Mai le TP; Thiem VD; Azim T; Victor JC; Dallas MJ; Steele AD; Neuzil KM; Ciarlet M
Vaccine; 2012 Apr; 30 Suppl 1():A106-13. PubMed ID: 22520119
[TBL] [Abstract][Full Text] [Related]
20. Amount of maternal rotavirus-specific antibodies influence the outcome of rotavirus vaccination of newborn mice with virus-like particles.
Johansson E; Istrate C; Charpilienne A; Cohen J; Hinkula J; Poncet D; Svensson L; Johansen K
Vaccine; 2008 Feb; 26(6):778-85. PubMed ID: 18191310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
